Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus

Endocrine Reviews

Volumn 37, Issue 3, 2016, Pages 278-316

  Kautzky Willer, Alexandra ^a   Harreiter, Jürgen ^a   Pacini, Giovanni ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ALCOHOL; ANDROGEN; ENDOCRINE DISRUPTOR; ESTROGEN; INCRETIN; SUGAR;

ALCOHOL CONSUMPTION; BEVERAGE; BODY FAT DISTRIBUTION; BODY MASS; BROWN ADIPOSE TISSUE; CARDIOMYOPATHY; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIABETIC FOOT; DIABETIC NEPHROPATHY; ENERGY RESOURCE; EPIGENETICS; GENETIC PREDISPOSITION; GLUCOSE ABSORPTION; GLUCOSE TOLERANCE; HEALTH BEHAVIOR; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; JOB STRESS; LARGE FOR GESTATIONAL AGE; LIFESTYLE; MEDLINE; MENTAL DISEASE; MENTAL STRESS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERSONAL EXPERIENCE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REPRODUCTION; REVIEW; RISK FACTOR; SEX CHROMOSOME; SEX DIFFERENCE; SEXUAL FUNCTION; SLEEP DEPRIVATION; SMOKING; SOCIAL PSYCHOLOGY; SOCIAL STATUS; STOMACH EMPTYING; COMPLICATION; DIABETIC COMPLICATION; FEMALE; MALE;

DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE;

EID: 84973861976     PISSN: None     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2015-1137     Document Type: Review

References (367)

1. Schiebinger L, Klinge I, Sánchez de Madariaga I, Paik H, Schraudner M, Stefanick M. Gendered innovations in science, health, medicine, engineering and environment. 2011-2015. Available at http://genderedinnovations.stanford.edu/. Accessed January 10, 2015.
2. Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014; 384: 766-781.
3. EUGen Med Cardiovascular Clinical Study Group, Regitz-Zagrosek V, Oertelt-Prigione S, et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016; 37: 24-34.
4. Annandale E, Riska E. Newconnections: towards a genderinclusive approach to women's and men's health. Curr Sociol. 2009; 57: 123-133.
5. Geary N. Counterpoint: physiologists should not distinguish "sex" and "gender". Am J Physiol Regul Integr Comp Physiol. 2010; 298: R1702-R1704.
6. Hammarström A, Annandale E. A conceptual muddle: an empirical analysis of the use of 'sex' and 'gender' in 'genderspecific medicine' journals. PLoS One. 2012; 7: e34193.
7. Wells JC, Marphatia AA, Cole TJ, McCoy D. Associations of economic and gender inequality with global obesity prevalence: understanding the female excess. Soc Sci Med. 2012; 75: 482-490.
8. Pickett KE, Kelly S, Brunner E, Lobstein T, Wilkinson RG. Wider income gaps, wider waistbands? Anecological study of obesity and income inequality. J Epidemiol Community Health. 2005; 59: 670-674.
9. Garawi F, Devries K, Thorogood N, Uauy R. Global differences between women and men in the prevalence of obesity: is there an association with gender inequality? Eur J Clin Nutr. 2014; 68: 1101-1106.
10. Zhang Q, Wang Y. Socioeconomic inequality of obesity in the United States: do gender, age, and ethnicity matter? Soc Sci Med. 2004; 58: 1171-1180.
11. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2013.
12. Tobias M. Global control of diabetes: information for action. Lancet. 2011; 378: 3-4.
13. Logue J, Walker JJ, Colhoun HM, et al. Do men develop type 2 diabetes at lower body mass indices than women. Diabetologia. 2011; 54: 3003-3006.
14. Wändell PE, Carlsson AC. Gender differences and time trends in incidence and prevalence of type 2 diabetes in Sweden-a model explaining the diabetes epidemic worldwide today? Diabetes Res Clin Pract. 2014; 106: e90-e92.
15. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004; 89: 2583-2589.
16. Power ML, Schulkin J. Sex differences in fat storage, fat metabolism, and the health risks from obesity: possible evolutionary origins. Br J Nutr. 2008; 99: 931-940.
17. Nielsen S, Guo Z, Johnson CM, Hensrud DD, Jensen MD. Splanchnic lipolysis in human obesity. J Clin Invest. 2004; 113: 1582-1588.
18. Westerbacka J, Cornér A, Tiikkainen M, et al. Womenand men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk. Diabetologia. 2004; 47: 1360-1369.
19. He H, Ni Y, Chen J, et al. Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity. Transl Res. 2010; 155: 71-77.
20. Williams CM. Lipid metabolism in women. Proc Nutr Soc. 2004; 63: 153-160.
21. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obedoi: sity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med. 2005; 165: 777-783.
22. Hu G, Bouchard C, Bray GA, et al. Trunk versus extremity adiposity and cardiometabolic risk factors in white and African American adults. Diabetes Care. 2011; 34: 1415-1418.
23. Carr MC, Brunzell JD. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab. 2004; 89: 2601-2607.
24. Kuk JL, Lee S, Heymsfield SB, Ross R. Waist circumference and abdominal adipose tissue distribution: influence of age and sex. Am J Clin Nutr. 2005; 81: 1330-1334.
25. Wannamethee SG, Papacosta O, Whincup PH, et al. Assessing prediction of diabetes in older adults using different adiposity measures: a 7 year prospective study in 6, 923 older men and women. Diabetologia. 2010; 53: 890-898.
26. Meisinger C, Döring A, Thorand B, Heier M, Löwel H. Body fat distribution and risk of type 2 diabetes in the general population: are there differences between men and women? The MONICA/KORA Augsburg cohort study. Am J Clin Nutr. 2006; 84: 483-489.
27. Schulze MB, Heidemann C, Schienkiewitz A, Bergmann MM, Hoffmann K, Boeing H. Comparison of anthropometric characteristics in predicting the incidence of type 2 diabetes in the EPIC-Potsdam study. Diabetes Care. 2006; 29: 1921-1923.
28. Hartwig S, Greiser KH, Medenwald D, et al. Association of change of anthropometric measurements with incident type 2 diabetes mellitus: a pooled analysis of the prospective population-based CARLA and SHIP cohort studies. Medicine (Baltimore). 2015; 94: e1394.
29. Wang Q, Zhang M, Xu M, et al. Brown adipose tissue activation is inversely related to central obesity and metabolic parameters in adult human. PLoS One. 2015; 10: e0123795.
30. Grefhorst A, van den Beukel JC, van Houten EL, Steenbergen J, Visser JA, Themmen AP. Estrogens increase expression of bone morphogenetic protein 8b in brown adipose tissue of mice. Biol Sex Differ. 2015; 6: 7.
31. Liu X, Wang S, You Y, et al. Brown adipose tissue transplantation reverses obesity in ob/ob mice. Endocrinology. 2015; 156: 2461-2469.
32. Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U. S. adults: NHANES III to NHANES1999-2006. Diabetes Care. 2011; 34: 216-219.
33. Wannamethee SG, Papacosta O, Lawlor DA, et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia. 2012; 55: 80-87.
34. Xu S, Gao B, Xing Y, et al. Gender differences in the prevalence and development of metabolic syndrome in Chinese population with abdominal obesity. PLoS One. 2013; 8: e78270.
35. Relimpio F, Martinez-Brocca MA, Leal-Cerro A, et al. Variability in the presence of the metabolic syndrome in type 2 diabetic patients attending a diabetes clinic. Influences of age and gender. Diabetes Res Clin Pract. 2004; 65: 135-142.
36. Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: association with mortality risk. Diabetes Care. 2010; 33: 2457-2461.
37. Sattar N. Gender aspects in type 2 diabetes mellitus and cardiometabolic risk. Best Pract Res Clin Endocrinol Metab. 2013; 27: 501-507.
38. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012; 379: 2279-2290.
39. van Vliet-Ostaptchouk JV, Nuotio ML, Slagter SN, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014; 14: 9.
40. Bell JA, Kivimaki M, Hamer M. Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev. 2014; 15: 504-515.
41. Chen GC, Qin LQ, Ye JK. Leptin levels and risk of type 2 diabetes: gender-specific meta-analysis. Obes Rev. 2014; 15: 134-142.
42. Laughlin GA, Barrett-Connor E, Cummins KM, Daniels LB, Wassel CL, Ix JH. Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo Study. Diabetes Care. 2013; 36: 1994-2000.
43. Amitani M, Asakawa A, Amitani H, Inui A. The role of leptin in the control of insulin-glucose axis. Front Neurosci. 2013; 7: 51.
44. Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005; 26: 439-451.
45. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and metaanalysis. JAMA. 2009; 302: 179-188.
46. Bonneau GA, Pedrozo WR, Berg G. Adiponectin and waist circumference as predictors of insulin-resistance inwomen. Diabetes Metab Syndr. 2014; 8: 3-7.
47. Rasul S, Ilhan A, Reiter MH, Baumgartner-Parzer S, Kautzky-Willer A. Relations of adiponectin to levels of metabolic parameters and sexual hormones in elderly type 2 diabetic patients. Gend Med. 2011; 8: 93-102.
48. Abbasi A, Corpeleijn E, Meijer E, et al. Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. Diabetologia. 2012; 55: 1963-1970.
49. Daniels LB, Maisel AS. Cardiovascular biomarkers and sex: the case for women. Nat Rev Cardiol. 2015; 12: 588-596.
50. Melander O, Maisel AS, Almgren P, et al. Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. JAMA. 2012; 308: 1469-1475.
51. Stadlmayr A, Aigner E, Huber-Schönauer U, et al. Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians. Acta Diabetol. 2015; 52: 39-46.
52. Song Y, Wang L, Pittas AG, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013; 36: 1422-1428.
53. Lee BK, Park S, Kim Y. Age- and gender-specific associations between low serum 25-hydroxyvitamin D level and type 2 diabetes in the Korean general population: analysis of 2008-2009 Korean National Health and Nutrition Examination Survey data. Asia Pac J Clin Nutr. 2012; 21: 536-546.
54. Maestro B, Campión J, Dávila N, Calle C. Stimulation by 1, 25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000; 47: 383-391.
55. Schneider AL, Lazo M, Ndumele CE, et al. Liver enzymes, race, gender and diabetes risk: the Atherosclerosis Risk in Communities (ARIC) study. Diabet Med. 2013; 30: 926-933.
56. Hocking S, Samocha-Bonet D, Milner KL, Greenfield JR, Chisholm DJ. Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots. Endocr Rev. 2013; 34: 463-500.
57. Pan JJ, Fallon MB. Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol. 2014; 6: 274-283.
58. Cicero AF, D'Addato S, Reggi A, Marchesini G, Borghi C. Gender difference in hepatic steatosis index and lipid accumulation product ability to predict incident metabolic syndrome in the historical cohort of the Brisighella Heart study. Metab Syndr Relat Disord. 2013; 11: 412-416.
59. Buday B, Pach PF, Literati-Nagy B, et al. Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: why alanine aminotransferase only predicts cardiovascular risk in men? Cardiovasc Diabetol. 2015; 14: 55.
60. Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009; 361: 1152-1163.
61. Peter A, Kantartzis K, Machann J, et al. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes. 2010; 59: 3167-3173.
62. Mather KJ, Kim C, Christophi CA, et al. Steroid sex hormones, sex hormone-binding globulin, and diabetes incidence in the diabetes prevention program. J Clin Endocrinol Metab. 2015; 100: 3778-3786.
63. Mauvais-Jarvis F. Letter to the editor: "steroid sex hormones, sex hormone-binding globulin, and diabetes incidence in the diabetes prevention program" by Mather KJ, et al. J Clin Endocrinol Metab. 2015; 100: L126-L127.
64. Fenske B, Kische H, Gross S, et al. Endogenous androgens and sex hormone-binding globulin in women and risk of metabolic syndrome and type 2 diabetes. J Clin Endocrinol Metab. 2015: 100: 4595-4603.
65. Varlamov O, Bethea CL, Roberts CT Jr. Sex-specific differences in lipid and glucose metabolism. Front Endocrinol (Lausanne). 2014; 5: 241.
66. Mauvais-Jarvis F. Sex differences in metabolic homeostasis, diabetes, and obesity. Biol Sex Differ. 2015; 6: 14.
67. Lovejoy JC, Sainsbury A. Sex differences in obesity and the regulation of energy homeostasis. Obes Rev. 2009; 10: 154-167.
68. Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 2013; 34: 309-338.
69. Navarro G, Allard C, Xu W, Mauvais-Jarvis F. The role of androgens in metabolism, obesity, and diabetes in males and females. Obesity (Silver Spring). 2015; 23: 713-719.
70. Elbers JM, Asscheman H, Seidell JC, Megens JA, Gooren LJ. Long-term testosterone administration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab. 1997; 82: 2044-2047.
71. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006; 295: 1288-1299.
72. Jayasena CN, Franks S. The management of patients with polycystic ovary syndrome. Nat Rev Endocrinol. 2014; 10: 624-636.
73. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010; 16: 347-363.
74. Coviello AD, Sam S, Legro RS, Dunaif A. High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metab. 2009; 94: 4361-4366.
75. Kobaly K, Vellanki P, Sisk RK, et al. Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome. J Clin Endocrinol Metab. 2014; 99: 2961-2966.
76. Rao PM, Kelly DM, Jones TH. Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nat Rev Endocrinol. 2013; 9: 479-493.
77. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. Int J Impot Res. 2000; 12: 305-311.
78. Zitzmann M. Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol. 2009; 5: 673-681.
79. Grossmann M. Low testosterone in men with type 2 diabetes: significance and treatment. J Clin Endocrinol Metab. 2011; 96: 2341-2353.
80. Grossmann M. Testosterone and glucose metabolism in men: current concepts and controversies. J Endocrinol. 2014; 220: R37-R55.
81. Jones TH, Arver S, Behre HM, et al. Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study). Diabetes Care. 2011; 34: 828-837.
82. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002; 19: 708-723.
83. Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia. 2006; 49: 2837-2846.
84. Huang Y, Cai X, Chen P, et al. Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis. Ann Med. 2014; 46: 684-692.
85. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009; 373: 1773-1779.
86. Ratner RE, Christophi CA, Metzger BE, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008; 93: 4774-4779.
87. Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. 2012; 8: 639-649.
88. Persson M, Fadl H. Perinatal outcome in relation to fetal sex in offspring to mothers with pre-gestational and gestational diabetes-a population-based study. Diabet Med. 2014; 31: 1047-1054.
89. Retnakaran R, Kramer CK, Ye C, et al. Fetal sex and maternal risk of gestational diabetes mellitus: the impact of having a boy. Diabetes Care. 2015; 38: 844-851.
90. Retnakaran R, Shah BR. Fetal sex and the natural history of maternal risk of diabetes during and after pregnancy. J Clin Endocrinol Metab. 2015; 100: 2574-2580.
91. Retnakaran R, Shah BR. Sex of the baby and future maternal risk of type 2 diabetes inwomenwhohad gestational diabetes. [published ahead of print October 15, 2015]. Diabet Med. 2015. doi:10.1111/dme.12989.
92. Lee DS, Kim YJ, Han HR. Sex differences in the association between socio-economic status and type 2 diabetes: data from the 2005 Korean National Health and Nutritional Examination Survey (KNHANES). Public Health. 2013; 127: 554-560.
93. Kautzky-Willer A, Dorner T, Jensby A, Rieder A. Women show a closer association between educational level and hypertension or diabetes mellitus than males: a secondary analysis from the Austrian HIS. BMCPublic Health. 2012; 12: 392.
94. Tang M, Chen Y, Krewski D. Gender-related differences in the association between socioeconomic status and self-reported diabetes. Int J Epidemiol. 2003; 32: 381-385.
95. Rathmann W, Haastert B, Icks A, et al. Sex differences in the associations of socioeconomic status with undiagnosed diabetes mellitus and impaired glucose tolerance in the elderly population: the KORA Survey 2000. Eur J Public Health. 2005; 15: 627-633.
96. Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis. Int J Epidemiol. 2011; 40: 804-818.
97. Rivera LA, Lebenbaum M, Rosella LC. The influence of socioeconomic status on future risk for developing type 2 diabetes in the Canadian population between 2011 and 2022: differential associations by sex. Int J Equity Health. 2015; 14: 101.
98. Maty SC, Lynch JW, Raghunathan TE, Kaplan GA. Childhood socioeconomic position, gender, adult body mass index, and incidence of type 2 diabetes mellitus over 34 years in the Alameda County Study. Am J Public Health. 2008; 98: 1486-1494.
99. Krajnak KM. Potential contribution of work-related psychosocial stress to the development of cardiovascular disease and type II diabetes: a brief review. Environ Health Insights. 2014; 8: 41-45.
100. Eriksson AK, van den Donk M, Hilding A, Östenson CG. Work stress, sense of coherence, and risk of type 2 diabetes in a prospective study of middle-aged Swedish men and women. Diabetes Care. 2013; 36: 2683-2689.
101. Norberg M, Stenlund H, Lindahl B, Andersson C, Eriksson JW, Weinehall L. Work stress and low emotional support is associated with increased risk of future type 2 diabetes in women. Diabetes Res Clin Pract. 2007; 76: 368-377.
102. Heraclides AM, Chandola T, Witte DR, Brunner EJ. Work stress, obesity and the risk of type 2 diabetes: gender-specific bidirectional effect in the Whitehall II study. Obesity (Silver Spring). 2012; 20: 428-433.
103. Pan A, Schernhammer ES, Sun Q, Hu FB. Rotating night shift work and risk of type 2 diabetes: two prospective cohort studies in women. PLoS Med. 2011; 8: e1001141.
104. Vetter C, Devore EE, Ramin CA, Speizer FE, Willett WC, Schernhammer ES. Mismatch of sleep andworktiming and risk of type 2 diabetes. Diabetes Care. 2015; 38: 1707-1713.
105. Silva-Costa A, Rotenberg L, Nobre AA, Schmidt MI, Chor D, Griep RH. Gender-specific association between nightwork exposure and type-2 diabetes: results from longitudinal study of adult health, ELSA-Brasil. Scand J Work Environ Health. 2015; 41: 568-578.
106. Spaeth AM, Dinges DF, Goel N. Sex and race differences in caloric intake during sleep restriction in healthy adults. Am J Clin Nutr. 2014; 100: 559-566.
107. Gan Y, Yang C, Tong X, et al. Shift work and diabetes mellitus: a meta-analysis of observational studies. Occup Environ Med. 2015; 72: 72-78.
108. Yu JH, Yun CH, Ahn JH, et al. Evening chronotype is associated with metabolic disorders and body composition in middle-aged adults. J Clin Endocrinol Metab. 2015; 100: 1494-1502.
109. Lundberg U. Stress hormones in health and illness: the roles of work and gender. Psychoneuroendocrinology. 2005; 30: 1017-1021.
110. Berntsson L, Lundberg U, Krantz G. Gender differences in work-home interplay and symptom perception among Swedish white-collar employees. J Epidemiol Community Health. 2006; 60: 1070-1076.
111. McEwen BS, Gray JD, Nasca C. 60 years of neuroendocrinology: redefining neuroendocrinology: stress, sex and cognitive and emotional regulation. J Endocrinol. 2015; 226: T67-T83.
112. Zhang B, Wing YK. Sex differences in insomnia: a metaanalysis. Sleep. 2006; 29: 85-93.
113. Schmid SM, Hallschmid M, Schultes B. The metabolic burden of sleep loss. Lancet Diabetes Endocrinol. 2015; 3: 52-62.
114. Gangwisch JE, Feskanich D, Malaspina D, Shen S, Forman JP. Sleep duration and risk for hypertension in women: results from the nurses' health study. Am J Hypertens. 2013; 26: 903-911.
115. Cappuccio FP, Stranges S, Kandala NB, et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II study. Hypertension. 2007; 50: 693-700.
116. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010; 33: 414-420.
117. Huth C, Thorand B, Baumert J, et al. Job strain as a risk factor for the onset of type 2 diabetes mellitus: findings from the MONICA/KORA Augsburg cohort study. Psychosom Med. 2014; 76: 562-568.
118. Leproult R, Holmbäck U, Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes. 2014; 63: 1860-1869.
119. Kriska AM, Edelstein SL, Hamman RF, et al. Physical activity in individuals at risk for diabetes: Diabetes Prevention Program. Med Sci Sports Exerc. 2006; 38: 826-832.
120. Nelson KM, Reiber G, Boyko EJ. Diet and exercise among adults with type 2 diabetes: findings from the third national health and nutrition examination survey (NHANES III). Diabetes Care. 2002; 25: 1722-1728.
121. Meisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med. 2002; 162: 82-89.
122. Ladabaum U, Mannalithara A, Myer PA, Singh G. Obesity, abdominal obesity, physical activity, and caloric intake in US adults: 1988 to 2010. Am J Med. 2014; 127: 717-727. e712.
123. Hare-Bruun H, Flint A, Heitmann BL. Glycemic index and glycemic load in relation to changes in body weight, body fat distribution, and body composition in adult Danes. Am J Clin Nutr. 2006; 84: 871-879; quiz 952-873.
124. Barclay AW, Petocz P, McMillan-Price J, et al. Glycemic index, glycemic load, and chronic disease risk-a metaanalysis of observational studies. Am J Clin Nutr. 2008; 87: 627-637.
125. Pieroni L, Salmasi L. Fast-food consumption and body weight. Evidence from the UK. Food Policy. 2014; 46: 94-105.
126. Malik VS, Popkin BM, Bray GA, et al. Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care. 2010; 33: 2477-2483.
127. Qi Q, Chu AY, Kang JH, et al. Sugar-sweetened beverages and genetic risk of obesity. NEngl J Med. 2012; 367: 1387-1396.
128. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004; 292: 927-934.
129. Eshak ES, Iso H, Mizoue T, Inoue M, Noda M, Tsugane S. Soft drink, 100% fruit juice, and vegetable juice intakes and risk of diabetes mellitus. Clin Nutr. 2013; 32: 300-308.
130. Singh GM, Micha R, Khatibzadeh S, Lim S, Ezzati M, Mozaffarian D. Estimated global, regional, and national disease burdens related to sugar-sweetened beverage consumption in 2010. Circulation. 2015; 132: 639-666.
131. Knott C, Bell S, Britton A. Alcohol consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of more than 1. 9 million individuals from 38 observational studies. Diabetes Care. 2015; 38: 1804-1812.
132. Schrieks IC, Heil AL, Hendriks HF, Mukamal KJ, Beulens JW. The effect of alcohol consumption on insulin sensitivity and glycemic status: a systematic review and meta-analysis of intervention studies. Diabetes Care. 2015; 38: 723-732.
133. Rohwer RD, Liu S, You NC, Buring JE, Manson JE, Song Y. Interrelationship between alcohol intake and endogenous sex-steroid hormones on diabetes risk in postmenopausal women. J Am Coll Nutr. 2015; 34: 273-280.
134. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007; 298: 2654-2664.
135. Inter Act Consortium, Spijkerman AM, van der ADL, et al. Smoking and long-term risk of type 2 diabetes: the EPICInter Act study in European populations. Diabetes Care. 2014; 37: 3164-3171.
136. Pan A, Wang Y, Talaei M, Hu FB, Wu T. Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015; 3: 958-967.
137. Raho E, van Oostrom SH, Visser M, et al. Generation shifts in smoking over 20 years in two Dutch population-based cohorts aged 20-100 years. BMCPublic Health. 2015; 15: 142.
138. Huxley RR, Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet. 2011; 378: 1297-1305.
139. Kaminsky Z, Wang SC, Petronis A. Complex disease, gender and epigenetics. Ann Med. 2006; 38: 530-544.
140. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008; 359: 61-73.
141. Dunn GA, Morgan CP, Bale TL. Sex-specificity in transgenerational epigenetic programming. Horm Behav. 2011; 59: 290-295.
142. Jimenez-Chillaron JC, Isganaitis E, Charalambous M, et al. Intergenerational transmission of glucose intolerance and obesity by in utero undernutrition in mice. Diabetes. 2009; 58: 460-468.
143. Ding GL, Wang FF, Shu J, et al. Transgenerational glucose intolerance with Igf2/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia. Diabetes. 2012; 61: 1133-1142.
144. Jia Y, Cong R, Li R, et al. Maternal low-protein diet induces gender-dependent changes in epigenetic regulation of the glucose-6-phosphatase gene in newborn piglet liver. J Nutr. 2012; 142: 1659-1665.
145. Yokomizo H, Inoguchi T, Sonoda N, et al. Maternal highfat diet induces insulin resistance and deterioration of pancreatic β -cell function in adult offspring with sex differences in mice. Am J Physiol Endocrinol Metab. 2014; 306: E1163-E1175.
146. Samuelsson AM, Matthews PA, Argenton M, et al. Dietinduced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming. Hypertension. 2008; 51: 383-392.
147. Huypens P, Sass S, Wu M, et al. Epigenetic germline inheritance of diet-induced obesity and insulin resistance. Nat Genet. 2016; 48: 497-499.
148. Dearden L, Balthasar N. Sexual dimorphism in offspring glucose-sensitive hypothalamic gene expression and physiological responses to maternal high-fat diet feeding. Endocrinology. 2014; 155: 2144-2154.
149. Plagemann A. Perinatal Programming: The State of the Art. Berlin, Boston: De Gruyter; 2012.
150. Vogt MC, Paeger L, Hess S, et al. Neonatal insulin action impairs hypothalamic neurocircuit formation in response to maternal high-fat feeding. Cell. 2014; 156: 495-509.
151. Chong AC, Vogt MC, Hill AS, Brüning JC, Zeltser LM. Central insulin signaling modulates hypothalamus-pituitary-adrenal axis responsiveness. Mol Metab. 2015; 4: 83-92.
152. Thurner S, Klimek P, Szell M, et al. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century. Proc Natl Acad Sci USA. 2013; 110: 4703-4707.
153. de Rooij SR, Painter RC, Roseboom TJ, et al. Glucose tolerance at age 58 and the decline of glucose tolerance in comparison with age 50 in people prenatally exposed to the Dutch famine. Diabetologia. 2006; 49: 637-643.
154. Ravelli AC, van der Meulen JH, Michels RP, et al. Glucose tolerance in adults after prenatal exposure to famine. Lancet. 1998; 351: 173-177.
155. Tobi EW, Lumey LH, Talens RP, et al. DNA methylation differences after exposure to prenatal famine are common and timing- and sex-specific. Hum Mol Genet. 2009; 18: 4046-4053.
156. Ravelli AC, van Der Meulen JH, Osmond C, Barker DJ, Bleker OP. Obesity at the age of 50 y in men and women exposed to famine prenatally. Am J Clin Nutr. 1999; 70: 811-816.
157. Ericson U, Rukh G, Stojkovic I, et al. Sex-specific interactions between the IRS1 polymorphism and intakes of carbohydrates and fat on incident type 2 diabetes. Am J Clin Nutr. 2013; 97: 208-216.
158. Aldhous MC, Reynolds RM, Campbell A, et al. Sex-differences in the metabolic health of offspring of parents with diabetes: a record-linkage study. PLoS One. 2015; 10: e0134883.
159. Wang C, Yatsuya H, Tamakoshi K, et al. Association between parental history of diabetes and the incidence of type 2 diabetes mellitus differs according to the sex of the parent and offspring's body weight: a finding from a Japanese worksite-based cohort study. Prev Med. 2015; 81: 49-53.
160. Jaddoe VW, de Jonge LL, van Dam RM, et al. Fetal exposure to parental smoking and the risk of type 2 diabetes in adult women. Diabetes Care. 2014; 37: 2966-2973.
161. Gabory A, Roseboom TJ, Moore T, Moore LG, Junien C. Placental contribution to the origins of sexual dimorphism in health and diseases: sex chromosomes and epigenetics. Biol Sex Differ. 2013; 4: 5.
162. Rosenfeld CS. Sex-specific placental responses in fetal development. Endocrinology. 2015; 156: 3422-3434.
163. Walsh JM, Segurado R, Mahony RM, Foley ME, McAuliffe FM. The effects of fetal gender on maternal and fetal insulin resistance. PLoS One. 2015; 10: e0137215.
164. Wilkin TJ, Murphy MJ. The gender insulin hypothesis: why girls are born lighter than boys, and the implications for insulin resistance. Int J Obes (Lond). 2006; 30: 1056-1061.
165. Rodríguez G, Samper MP, Ventura P, Moreno LA, Olivares JL, Pérez-González JM. Gender differences in newborn subcutaneous fat distribution. Eur J Pediatr. 2004; 163: 457-461.
166. Eder M, Csapo B, Wadsack C, et al. Sex differences in the association of cord blood insulin with subcutaneous adipose tissue in neonates. Int J Obes (Lond). 2016; 40: 538-542.
167. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA. 2008; 300: 2886-2897.
168. Johnsson IW, Haglund B, Ahlsson F, Gustafsson J. A high birth weight is associated with increased risk of type 2 diabetes and obesity. Pediatr Obes. 2015; 10: 77-83.
169. Zimmermann E, Gamborg M, Sørensen TI, Baker JL. Sex differences in the association between birth weight and adult type 2 diabetes. Diabetes. 2015; 64: 4220-4225.
170. Sato R, Watanabe H, Shirai K, et al. Across-sectional study of glucose regulation in young adults with very low birth weight: impact of male gender on hyperglycaemia. BMJ Open. 2012; 2: e000327.
171. Richter VF, Briffa JF, Moritz KM, Wlodek ME, Hryciw DH. The role of maternal nutrition, metabolic function and the placenta in developmental programming of renal dysfunction. Clin Exp Pharmacol Physiol. 2016; 43: 135-141.
172. Dalziel SR, Walker NK, Parag V, et al. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-year follow-up of a randomised controlled trial. Lancet. 2005; 365: 1856-1862.
173. Alexander N, Rosenlöcher F, Stalder T, et al. Impact of antenatal synthetic glucocorticoid exposure on endocrine stress reactivity in term-born children. J Clin Endocrinol Metab. 2012; 97: 3538-3544.
174. Reynolds RM, Walker BR, Syddall HE, Andrew R, Wood PJ, Phillips DI. Is there a gender difference in the associations of birthweight and adult hypothalamic-pituitary-adrenal axis activity? Eur J Endocrinol. 2005; 152: 249-253.
175. McCormick CM, Smythe JW, Sharma S, Meaney MJ. Sexspecific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Brain Res Dev Brain Res. 1995; 84: 55-61.
176. Weinstock M, Matlina E, Maor GI, Rosen H, McEwen BS. Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res. 1992; 595: 195-200.
177. Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009; 5: 374-381.
178. Doyle LW, Ford GW, Davis NM, Callanan C. Antenatal corticosteroid therapy and blood pressure at 14 years of age in preterm children. Clin Sci. 2000; 98: 137-142.
179. Lee DH, Porta M, Jacobs DR Jr, Vandenberg LN. Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr Rev. 2014; 35: 557-601.
180. Huang T, Saxena AR, Isganaitis E, James-Todd T. Gender and racial/ethnic differences in the associations of urinary phthalate metabolites with markers of diabetes risk: National Health and Nutrition Examination Survey 2001-2008. Environ Health. 2014; 13: 6.
181. Ashley-Martin J, Dodds L, Arbuckle TE, et al. A birth cohort study to investigate the association between prenatal phthalate and bisphenol A exposures and fetal markers of metabolic dysfunction. Environ Health. 2014; 13: 84.
182. Volberg V, Harley K, Calafat AM, et al. Maternal bisphenol a exposure during pregnancy and its association with adipokines in Mexican-American children. Environ Mol Mutagen. 2013; 54: 621-628.
183. Watkins DJ, Peterson KE, Ferguson KK, et al. Relating phthalate and BPA exposure to metabolism in peripubescence: the role of exposure timing, sex, and puberty. J Clin Endocrinol Metab. 2016: 101: 79-88.
184. Jalouli M, Carlsson L, Améen C, et al. Sex difference in hepatic peroxisome proliferator-activated receptor α expression: influence of pituitary and gonadal hormones. Endocrinology. 2003; 144: 101-109.
185. Yang X, Schadt EE, Wang S, et al. Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res. 2006; 16: 995-1004.
186. Cvitic S, Longtine MS, Hackl H, et al. The human placental sexome differs between trophoblast epithelium and villous vessel endothelium. PLoS One. 2013; 8: e79233.
187. Shungin D, Winkler TW, Croteau-Chonka DC, et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature. 2015; 518: 187-196.
188. Babelova A, Burckhardt BC, Salinas-Riester G, Pommerenke C, Burckhardt G, Henjakovic M. Next generation sequencing of sex-specific genes in the livers of obese ZSF1 rats. Genomics. 2015; 106: 204-213.
189. He T, Zhong PS, Cui Y. A set-based association test identifies sex-specific gene sets associated with type 2 diabetes. Front Genet. 2014; 5: 395.
190. Chen X, McClusky R, Chen J, et al. The number of x chromosomes causes sex differences in adiposity in mice. PLoS Genet. 2012; 8: e1002709.
191. Bonthuis PJ, Rissman EF. Neural growth hormone implicated in body weight sex differences. Endocrinology. 2013; 154: 3826-3835.
192. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42: 579-589.
193. Guigas B, de Leeuw van Weenen JE, van Leeuwen N, et al. Sex-specific effects of naturally occurring variants in the dopamine receptor D2 locus on insulin secretion and type 2 diabetes susceptibility. Diabet Med. 2014; 31: 1001-1008.
194. Ober C, Loisel DA, Gilad Y. Sex-specific genetic architecture of human disease. Nat Rev Genet. 2008; 9: 911-922.
195. Bonnefond A, Froguel P. Rare and common genetic events in type 2 diabetes: what should biologists know? Cell Metab. 2015; 21: 357-368.
196. Walford GA, Porneala BC, Dauriz M, et al. Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care. 2014; 37: 2508-2514.
197. Ahrén B, Pacini G. Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess β cell function in clinical studies. Eur J Endocrinol. 2004; 150: 97-104.
198. Pacini G. The hyperbolic equilibrium between insulin sensitivity and secretion. Nutr Metab Cardiovasc Dis. 2006; 16(suppl 1): S22-S27.
199. Kautzky-Willer A, Brazzale AR, Tura A, et al. Gender effect on insulin sensitivity and secretion in different categories of glucose tolerance. Diabetologia. 2009; 52: S210-S210.
200. Kautzky-Willer A, Brazzale AR, Moro E, et al. Influence of increasing BMI on insulin sensitivity and secretion in normotolerant men and women of a wide age span. Obesity (Silver Spring). 2012; 20: 1966-1973.
201. Le May C, Chu K, Hu M, et al. Estrogens protect pancreatic β -cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA. 2006; 103: 9232-9237.
202. Wong WP, Tiano JP, Liu S, et al. Extranuclear estrogen receptor-α stimulates Neuro D1 binding to the insulin promoter and favors insulin synthesis. Proc Natl Acad Sci USA. 2010; 107: 13057-13062.
203. Ribas V, Nguyen MT, Henstridge DC, et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERα -deficient mice. Am J Physiol Endocrinol Metab. 2010; 298: E304-E319.
204. Alonso-Magdalena P, Ropero AB, Carrera MP, et al. Pancreatic insulin content regulation by the estrogen receptor ER α. PLoS One. 2008; 3: e2069.
205. Pereira RI, Casey BA, Swibas TA, Erickson CB, Wolfe P, Van Pelt RE. Timing of estradiol treatment after menopause may determine benefit or harm to insulin action. J Clin Endocrinol Metab. 2015; 100: 4456-4462.
206. Mascarenhas-Melo F, Marado D, Palavra F, et al. Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women. Cardiovasc Diabetol. 2013; 12: 61.
207. Steinberg HO, Paradisi G, Cronin J, et al. Type II diabetes abrogates sex differences in endothelial function in premenopausal women. Circulation. 2000; 101: 2040-2046.
208. Peters SA, Huxley RR, Sattar N, Woodward M. Sex differences in the excess risk of cardiovascular diseases associated with type 2 diabetes: potential explanations and clinical implications. Curr Cardiovasc Risk Rep. 2015; 9: 36.
209. Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U. S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care. 1998; 21: 518-524.
210. Pacini G, Mari A. Methods for clinical assessment of insulin sensitivity and β -cell function. Best Pract Res Clin Endocrinol Metab. 2003; 17: 305-322.
211. Nauck MA. Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes. Horm Metab Res. 2004; 36: 852-858.
212. Færch K, Pacini G, Nolan JJ, Hansen T, Tura A, Vistisen D. Impact of glucose tolerance status, sex, and body size on glucose absorption patterns during OGTTs. Diabetes Care. 2013; 36: 3691-3697.
213. Phillips WT, Schwartz JG, McMahan CA. Rapid gastric emptying of an oral glucose solution in type 2 diabetic patients. J Nucl Med. 1992; 33: 1496-1500.
214. Jones KL, Russo A, Stevens JE, Wishart JM, Berry MK, Horowitz M. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001; 24: 1264-1269.
215. Basu R, Dalla Man C, Campioni M, et al. Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction. Diabetes. 2006; 55: 2001-2014.
216. Anderwald C, Gastaldelli A, Tura A, et al. Mechanism and effects of glucose absorption during an oral glucose tolerance test among females and males. J Clin Endocrinol Metab. 2011; 96: 515-524.
217. Perseghin G, Scifo P, Pagliato E, et al. Gender factors affect fatty acids-induced insulin resistance in nonobese humans: effects of oral steroidal contraception. J Clin Endocrinol Metab. 2001; 86: 3188-3196.
218. Moro C, Galgani JE, Luu L, et al. Influence of gender, obesity, and muscle lipase activity on intramyocellular lipids in sedentary individuals. J Clin Endocrinol Metab. 2009; 94: 3440-3447.
219. Ortiz-Nieto F, Johansson L, Ahlström H, Weis J. Quantification of lipids in human lower limbs using yellow bone marrow as the internal reference: gender-related effects. Magn Reson Imaging. 2010; 28: 676-682.
220. Tarnopolsky MA, Rennie CD, Robertshaw HA, Fedak-Tarnopolsky SN, Devries MC, Hamadeh MJ. Influence of endurance exercise training and sex on intramyocellular lipid and mitochondrial ultrastructure, substrate use, and mitochondrial enzyme activity. Am J Physiol Regul Integr Comp Physiol. 2007; 292: R1271-R1278.
221. Kautzky-Willer A, Krssak M, Winzer C, et al. Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes. 2003; 52: 244-251.
222. Prikoszovich T, Winzer C, Schmid AI, et al. Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus. Diabetes Care. 2011; 34: 430-436.
223. Tian GX, Sun Y, Pang CJ, et al. Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men. Obes Rev. 2012; 13: 381-387.
224. Bozkurt L, Gobl CS, Tura A, et al. Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetes. PLoS One. 2012; 7: e32710.
225. Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014; 57: 660-671.
226. Iozzo P, Lautamaki R, Borra R, et al. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab. 2009; 94: 4472-4482.
227. Krššák M, Winhofer Y, Göbl C, et al. Insulin resistance is not associated with myocardial steatosis in women. Diabetologia. 2011; 54: 1871-1878.
228. Winhofer Y, Krssak M, Wolf P, et al. Hepatic rather than cardiac steatosis relates to glucose intolerance in women with prior gestational diabetes. PLoS One. 2014; 9: e91607.
229. Palmer BF, Clegg DJ. The sexual dimorphism of obesity. Mol Cell Endocrinol. 2015; 402: 113-119.
230. Karastergiou K, Smith SR, Greenberg AS, Fried SK. Sex differences in human adipose tissues - the biology of pear shape. Biol Sex Differ. 2012; 3: 13.
231. Brown LM, Gent L, Davis K, Clegg DJ. Metabolic impact of sex hormones on obesity. Brain Res. 2010; 1350: 77-85.
232. Anderson LA, McTernan PG, Barnett AH, Kumar S. The effects of androgens and estrogens on preadipocyte proliferation in human adipose tissue: influence of gender and site. J Clin Endocrinol Metab. 2001; 86: 5045-5051.
233. Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by upregulating α 2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor α. Implications for the female fat distribution. J Clin Endocrinol Metab. 2004; 89: 1869-1878.
234. Okura T, Koda M, Ando F, Niino N, Ohta S, Shimokata H. Association of polymorphisms in the estrogen receptor α gene with body fat distribution. Int J Obes Relat Metab Disord. 2003; 27: 1020-1027.
235. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-α knockout mice. Proc Natl Acad Sci USA. 2000; 97: 12729-12734.
236. Siiteri PK. Adipose tissue as a source of hormones. Am J Clin Nutr. 1987; 45: 277-282.
237. Medrikova D, Jilkova ZM, Bardova K, Janovska P, Rossmeisl M, Kopecky J. Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control. Int J Obes (Lond). 2012; 36: 262-272.
238. Mårin P, Odén B, Björntorp P. Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab. 1995; 80: 239-243.
239. Finkelstein JS, Lee H, Burnett-Bowie SA, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013; 369: 1011-1022.
240. Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut. 2014; 63: 1513-1521.
241. Flak MB, Neves JF, Blumberg RS. Immunology. Welcome to the microgenderome. Science. 2013; 339: 1044-1045.
242. Law J, Bloor I, Budge H, Symonds ME. The influence of sex steroids on adipose tissue growth and function. Horm Mol Biol Clin Investig. 2014; 19: 13-24.
243. Vicennati V, Ceroni L, Genghini S, Patton L, Pagotto U, Pasquali R. Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity. Obesity (Silver Spring). 2006; 14: 235-243.
244. Gathercole LL, Lavery GG, Morgan SA, et al. 11β -hydroxysteroid dehydrogenase 1: translational and therapeutic aspects. Endocr Rev. 2013; 34: 525-555.
245. Bailey M, Silver R. Sex differences in circadian timing systems: implications for disease. Front Neuroendocrinol. 2014; 35: 111-139.
246. Arnetz L, Rajamand Ekberg N, Brismar K, Alvarsson M. Gender difference in adrenal sensitivity to ACTH is abolished in type 2 diabetes. Endocr Connect. 2015; 4: 92-99.
247. Pasquali R. The hypothalamic-pituitary-adrenal axis and sex hormones in chronic stress and obesity: pathophysiological and clinical aspects. Ann NY Acad Sci. 2012; 1264: 20-35.
248. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat Rev Neurosci. 2009; 10: 434-445.
249. Adam TC, Epel ES. Stress, eating and the reward system. Physiol Behav. 2007; 91: 449-458.
250. Wang GJ, Volkow ND, Telang F, et al. Evidence of gender differences in the ability to inhibit brain activation elicited by food stimulation. Proc Natl Acad Sci USA. 2009; 106: 1249-1254.
251. Gold PW. The organization of the stress system and its dysregulation in depressive illness. Mol Psychiatry. 2015; 20: 32-47.
252. Gobinath AR, Mahmoud R, Galea LA. Influence of sex and stress exposure across the lifespan on endophenotypes of depression: focus on behavior, glucocorticoids, and hippocampus. Front Neurosci. 2014; 8: 420.
253. Kivimaki M, Batty GD, Hublin C. Shift work as a risk factor for future type 2 diabetes: evidence, mechanisms, implications, and future research directions. PLoS Med. 2011; 8: e1001138.
254. Eckel-Mahan K, Sassone-Corsi P. Metabolism and the circadian clock converge. Physiol Rev. 2013; 93: 107-135.
255. Bouatia-Naji N, Bonnefond A, Cavalcanti-Proença C, et al. A variant near MTNR1B is associated with increased fasting plasma glucose levels and type 2 diabetes risk. Nat Genet. 2009; 41: 89-94.
256. Cipolla-Neto J, Amaral FG, Afeche SC, Tan DX, Reiter RJ. Melatonin, energy metabolism, and obesity: a review. J Pineal Res. 2014; 56: 371-381.
257. Obayashi K, Saeki K, Tone N, et al. Lower melatonin secretion in older females: gender differences independent of light exposure profiles. J Epidemiol. 2015; 25: 38-43.
258. Scheer FA, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. 2009; 106: 4453-4458.
259. Morris CJ, Yang JN, Garcia JI, et al. Endogenous circadian system and circadian misalignment impact glucose tolerance via separate mechanisms in humans. Proc Natl Acad Sci USA. 2015; 112: E2225-E2234.
260. Nohara K, Zhang Y, Waraich RS, et al. Early-life exposure to testosterone programs the hypothalamic melanocortin system. Endocrinology. 2011; 152: 1661-1669.
261. Shi H, Strader AD, Sorrell JE, Chambers JB, Woods SC, Seeley RJ. Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis. Am J Physiol Endocrinol Metab. 2008; 294: E630-E639.
262. Clegg DJ, Brown LM, Woods SC, Benoit SC. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes. 2006; 55: 978-987.
263. Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC. Differential sensitivity to central leptin and insulin in male and female rats. Diabetes. 2003; 52: 682-687.
264. Keen-Rhinehart E, Desai M, Ross MG. Central insulin sensitivity in male and female juvenile rats. Horm Behav. 2009; 56: 275-280.
265. Lindtner C, Scherer T, Zielinski E, et al. Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action. Sci Transl Med. 2013; 5: 170ra114.
266. Brüning JC, Gautam D, Burks DJ, et al. Role of brain insulin receptor in control of body weight and reproduction. Science. 2000; 289: 2122-2125.
267. Burke LK, Doslikova B, D'Agostino G, et al. Sex difference in physical activity, energy expenditure and obesity driven by a subpopulation of hypothalamic POMC neurons. Mol Metab. 2016; 5: 245-252.
268. Iwen KA, Scherer T, Heni M, et al. Intranasal insulin suppresses systemic but not subcutaneous lipolysis in healthy humans. J Clin Endocrinol Metab. 2014; 99: E246-E251.
269. Hallschmid M, Benedict C, Schultes B, Fehm HL, Born J, Kern W. Intranasal insulin reduces body fat in men but not in women. Diabetes. 2004; 53: 3024-3029.
270. Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008; 29: 932-940.
271. Catalan M, Herreras Z, Pinyol M, et al. Prevalence by sex of preclinical carotid atherosclerosis in newly diagnosed type 2 diabetes. Nutr Metab Cardiovasc Dis. 2015; 25: 742-748.
272. Onat A, Hergenç G, Keleş I, Doğan Y, Türkmen S, Sansoy V. Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome. Metabolism. 2005; 54: 800-808.
273. Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775, 385 individuals and 12, 539 strokes. Lancet. 2014; 383: 1973-1980.
274. Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858, 507 individuals and 28, 203 coronary events. Diabetologia. 2014; 57: 1542-1551.
275. Regitz-Zagrosek V. Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov. 2006; 5: 425-438.
276. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005; 308: 1583-1587.
277. Dantas AP, Fortes ZB, de Carvalho MH. Vascular disease in diabetic women: why do they miss the female protection. Exp Diabetes Res. 2012; 2012: 570598.
278. Cardillo C, Campia U, Bryant MB, Panza JA. Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation. 2002; 106: 1783-1787.
279. Zhang R, Thor D, Han X, Anderson L, Rahimian R. Sex differences in mesenteric endothelial function of streptozotocin-induced diabetic rats: a shift in the relative importance of EDRFs. Am J Physiol Heart Circ Physiol. 2012; 303: H1183-H1198.
280. Ortmann J, Veit M, Zingg S, et al. Estrogen receptor-α but not -β or GPER inhibits high glucose-induced human VSMCproliferation: potential role of ROS and ERK. J Clin Endocrinol Metab. 2011; 96: 220-228.
281. Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994; 331: 1056-1061.
282. Sudhir K, Chou TM, Messina LM, et al. Endothelial dysfunction in a man with disruptive mutation in oestrogenreceptor gene. Lancet. 1997; 349: 1146-1147.
283. Ergul A, Shoemaker K, Puett D, Tackett RL. Gender differences in the expression of endothelin receptors inhuman saphenous veins in vitro. J Pharmacol Exp Ther. 1998; 285: 511-517.
284. Stauffer BL, Westby CM, Greiner JJ, Van Guilder GP, Desouza CA. Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults. Am J Physiol Regul Integr Comp Physiol. 2010; 298: R261-R265.
285. Gogg S, Smith U, Jansson PA. Increased MAPK activation and impaired insulin signaling in subcutaneous microvascular endothelial cells in type 2 diabetes: the role of endothelin-1. Diabetes. 2009; 58: 2238-2245.
286. Matsumoto T, Kakami M, Kobayashi T, Kamata K. Gendoi: der differences in vascular reactivity to endothelin-1 (1-31) in mesenteric arteries from diabetic mice. Peptides. 2008; 29: 1338-1346.
287. Bowden MA, Tesch GH, Julius TL, Rosli S, Love JE, Ritchie RH. Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male mice. Obesity (Silver Spring). 2015; 23: 1166-1177.
288. Alzahrani SH, Hess K, Price JF, et al. Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers. J Clin Endocrinol Metab. 2012; 97: E2282-E2287.
289. Yetkin E, Topal E, Erguzel N, Senen K, Heper G, Waltenberger J. Diabetes mellitus and female gender are the strongest predictors of poor collateral vessel development in patients with severe coronary artery stenosis. Angiogenesis. 2015; 18: 201-207.
290. Kyriakides ZS, Petinakis P, Kaklamanis L, et al. Gender does not influence angiogenesis and arteriogenesis in a rabbit model of chronic hind limb ischemia. Int J Cardiol. 2003; 92: 83-91.
291. Lamping KG, Christensen LP, Tomanek RJ. Estrogen therapy induces collateral and microvascular remodeling. AmJ Physiol Heart Circ Physiol. 2003; 285: H2039-H2044.
292. Peterson LR, Saeed IM, McGill JB, et al. Sex and type 2 diabetes: obesity-independent effects on left ventricular substrate metabolism and relaxation in humans. Obesity (Silver Spring). 2012; 20: 802-810.
293. Peterson LR, Soto PF, Herrero P, et al. Impact of gender on the myocardial metabolic response to obesity. JACC Cardiovasc Imaging. 2008; 1: 424-433.
294. Lyons MR, Peterson LR, McGill JB, et al. Impact of sex on the heart's metabolic and functional responses to diabetic therapies. Am J Physiol Heart Circ Physiol. 2013; 305: H1584-H1591.
295. Peterson LR, Soto PF, Herrero P, Schechtman KB, Dence C, Gropler RJ. Sex differences in myocardial oxygen and glucose metabolism. J Nucl Cardiol. 2007; 14: 573-581.
296. Peterson LR, Herrero P, Coggan AR, et al. Type 2 diabetes, obesity, and sex difference affect the fate of glucose in the human heart. Am J Physiol Heart Circ Physiol. 2015; 308: H1510-H1516.
297. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56: 1113-1132.
298. Emerging Risk Factors Collaboration, Seshasai SR, Kaptoge S, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364: 829-841.
299. Policardo L, Seghieri G, Francesconi P, et al. Gender difference in diabetes-associated risk of first-ever and recurrent ischemic stroke. J Diabetes Complications. 2015; 29: 713-717.
300. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham study. JAMA. 1979; 241: 2035-2038.
301. Kiencke S, Handschin R, von Dahlen R, et al. Pre-clinical diabetic cardiomyopathy: prevalence, screening, and outcome. Eur J Heart Fail. 2010; 12: 951-957.
302. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002; 347: 305-313.
303. Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation. 2004; 109: 2191-2196.
304. Li W, Katzmarzyk PT, Horswell R, et al. Body mass index and heart failure among patients with type 2 diabetes. Circ Heart Fail. 2015; 8: 455-463.
305. Regitz-Zagrosek V, Brokat S, Tschope C. Role of gender in heart failure with normal left ventricular ejection fraction. Prog Cardiovasc Dis. 2007; 49: 241-251.
306. Bertoni AG, Tsai A, Kasper EK, Brancati FL. Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care. 2003; 26: 2791-2795.
307. Martínez-Sellés M, Doughty RN, Poppe K, et al. Gender and survival in patients with heart failure: interactions with diabetes and aetiology. Results from the MAGGIC individual patient meta-analysis. Eur J Heart Fail. 2012; 14: 473-479.
308. Reichelt ME, Mellor KM, Curl CL, Stapleton D, Delbridge LM. Myocardial glycophagy - a specific glycogen handling response to metabolic stress is accentuated in the female heart. J Mol Cell Cardiol. 2013; 65: 67-75.
309. Regitz-Zagrosek V, Oertelt-Prigione S, Seeland U, Hetzer R. Sex and gender differences in myocardial hypertrophy and heart failure. Circ J. 2010; 74: 1265-1273.
310. Regitz-Zagrosek V, Dworatzek E, Kintscher U, Dragun D. Sex and sex hormone-dependent cardiovascular stress responses. Hypertension. 2013; 61: 270-277.
311. Reichelt ME, Mellor KM, Bell JR, Chandramouli C, Headrick JP, Delbridge LM. Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus. Am J Physiol Heart Circ Physiol. 2013; 305: H779-H792.
312. Peek ME. Gender differences in diabetes-related lower extremity amputations. Clin Orthop Relat Res. 2011; 469: 1951-1955.
313. Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med. 2013; 30: 964-972.
314. Amin L, Shah BR, Bierman AS, et al. Gender differences in the impact of poverty on health: disparities in risk of diabetes-related amputation. Diabet Med. 2014; 31: 1410-1417.
315. Crawford F, Cezard G, Chappell FM, et al. A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). Health Technol Assess. 2015; 19.
316. Tseng CH. Sex difference in the distribution of atherosclerotic risk factors and their association with peripheral arterial disease in Taiwanese type 2 diabetic patients. Circ J. 2007; 71: 1131-1136.
317. Morbach S, Furchert H, Gröblinghoff U, et al. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012; 35: 2021-2027.
318. de Hauteclocque A, Ragot S, Slaoui Y, et al. The influence of sex on renal function decline in people with Type 2 diabetes. Diabet Med. 2014; 31: 1121-1128.
319. Carrero JJ, de Mutsert R, Axelsson J, et al. Sex differences in the impact of diabetes on mortality in chronic dialysis patients. Nephrol Dial Transplant. 2011; 26: 270-276.
320. Hecking M, Bieber BA, Ethier J, et al. Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the dialysis outcomes and practice patterns study (DOPPS). PLoS Med. 2014; 11: e1001750.
321. Gomez-Marcos MA, Recio-Rodriguez JI, Gomez-Sanchez L, et al. Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study. Cardiovasc Diabetol. 2015; 14: 132.
322. Villar E, Chang SH, McDonald SP. Incidences, treatments, outcomes, and sex effect on survival in patients with endstage renal disease by diabetes status in Australia and New Zealand (1991 2005). Diabetes Care. 2007; 30: 3070-3076.
323. Villar E, Remontet L, Labeeuw M, Ecochard R. Effect of age, gender, and diabetes on excess death in end-stage renal failure. J Am Soc Nephrol. 2007; 18: 2125-2134.
324. Tancredi M, Rosengren A, Svensson AM, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med. 2015; 373: 1720-1732.
325. Remuzzi A, Puntorieri S, Mazzoleni A, Remuzzi G. Sex related differences in glomerular ultrafiltration and proteinuria in Munich-Wistar rats. Kidney Int. 1988; 34: 481-486.
326. Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis. 1995; 25: 515-533.
327. Ajayi AA, Ogungbade GO, Okorodudu AO. Sex hormone regulation of systemic endothelial and renal microvascular reactivity in type-2 diabetes: studies in gonadectomized and sham-operated Zucker diabetic rats. Eur J Clin Invest. 2004; 34: 349-357.
328. Baltatu O, Cayla C, Iliescu R, Andreev D, Bader M. Abolition of end-organ damage by antiandrogen treatment in female hypertensive transgenic rats. Hypertension. 2003; 41: 830-833.
329. Baltatu O, Cayla C, Iliescu R, Andreev D, Jordan C, Bader M. Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J Am Soc Nephrol. 2002; 13: 2681-2687.
330. Lin CH, Yang WC, Tsai ST, Tung TH, Chou P. A community-based study of chronic kidney disease among type 2 diabetics in Kinmen, Taiwan. Diabetes Res Clin Pract. 2007; 75: 306-312.
331. Tien KJ, Hsiao JY, Hsu SC, et al. Gender-dependent effect of ACE I/D and AGT M235T polymorphisms on the progression of urinary albumin excretion in Taiwanese with type 2 diabetes. Am J Nephrol. 2009; 29: 299-308.
332. Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE. Gender is related to alterations of renal endothelial function in type 2 diabetes. Nephrol Dial Transplant. 2009; 24: 3354-3359.
333. Maric C. Sex, diabetes and the kidney. Am J Physiol Renal Physiol. 2009; 296: F680-F688.
334. Xu Q, Wells CC, Garman JH, Asico L, Escano CS, Maric C. Imbalance in sex hormone levels exacerbates diabetic renal disease. Hypertension. 2008; 51: 1218-1224.
335. McCollum M, Hansen LS, Lu L, Sullivan PW. Gender differences in diabetes mellitus and effects on self-care activity. Gend Med. 2005; 2: 246-254.
336. Chiu CJ, Wray LA. Gender differences in functional limitations in adults living with type 2 diabetes: biobehavioral and psychosocial mediators. Ann Behav Med. 2011; 41: 71-82.
337. Lu FP, Chang WC, Wu SC. Geriatric conditions, rather than multimorbidity, as predictors of disability and mortality among octogenarians: a population-based cohort study. Geriatr Gerontol Int. 2016; 16: 345-351.
338. Young-Hyman DL, Davis CL. Disordered eating behavior in individuals with diabetes: importance of context, evaluation, and classification. Diabetes Care. 2010; 33: 683-689.
339. Sullivan MD, O'Connor P, Feeney P, et al. Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy. Diabetes Care. 2012; 35: 1708-1715.
340. Siddiqui MA, Khan MF, Carline TE. Gender differences in living with diabetes mellitus. Mater Sociomed. 2013; 25: 140-142.
341. Dabelea D, Mayer-Davis EJ, Lamichhane AP, et al. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control study. Diabetes Care. 2008; 31: 1422-1426.
342. Wing RR, Bond DS, Gendrano IN 3rd, et al. Effect of intensive lifestyle intervention on sexual dysfunction in womenwith type 2 diabetes: results from an ancillary Look AHEAD study. Diabetes Care. 2013; 36: 2937-2944.
343. Wing RR, Rosen RC, Fava JL, et al. Effects of weight loss intervention on erectile function in older men with type 2 diabetes in the Look AHEAD trial. J Sex Med. 2010; 7: 156-165.
344. Rosen RC, Wing RR, Schneider S, et al. Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med. 2009; 6: 1414-1422.
345. Ma RC, SoWY, Yang X, et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol. 2008; 51: 2045-2050.
346. Collins FS, Tabak LA. Policy: NIH plans to enhance reproducibility. Nature. 2014; 505: 612-613.
347. Oertelt-Prigione S. Sex and gender in medical literature. In: Oertelt-Prigione S, Regitz-Zagrosek V, eds. Sex and Gender Aspects in Clinical Medicine. London, UK: Springer-Verlag; 2012: 9-15.
348. World Health Organization. Raised fasting blood glucose (≥ 7. 0 mmol/L or on medication). Data by country. Global Health Observatory Data Repository. 2015. Available at http://apps.who.int/gho/data/view.main.2469?lang=en. Accessed November 18, 2015.
349. El Ati J, Traissac P, Delpeuch F, et al. Gender obesity inequities are huge but differ greatly according to environment and socio-economics in a North African setting: a national cross-sectional study in Tunisia. PLoSOne. 2012; 7: e48153.
350. Coban N, Onat A, Yildirim O, Can G, Erginel-Unaltuna N. Oxidative stress-mediated (sex-specific) loss of protection against type-2 diabetes by macrophage migration indoi: hibitory factor (MIF)-173G/C polymorphism. Clin Chim Acta. 2015; 438: 1-6.
351. Fisher E, Li Y, Burwinkel B, et al. Preliminary evidence of FABP2 A54T polymorphism associated with reduced risk of type 2 diabetes and obesity in women from a German cohort. Horm Metab Res. 2006; 38: 341-345.
352. Li Y, Fisher E, Klapper M, et al. Association between functional FABP2 promoter haplotype and type 2 diabetes. Horm Metab Res. 2006; 38: 300-307.
353. Nordman S, Ding B, Ostenson CG, et al. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men. Exp Clin Endocrinol Diabetes. 2005; 113: 282-287.
354. D'Adamo M, Perego L, Cardellini M, et al. The-866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes. Diabetes. 2004; 53: 1905-1910.
355. Go MJ, Hwang JY, Park TJ, et al. Genome-wide association study identifies two novel Loci with sex-specific effects for type 2 diabetes mellitus and glycemic traits in a korean population. Diabetes Metab J. 2014; 38: 375-387.
356. McCarthy JJ, Somji A, Weiss LA, et al. Polymorphisms of the scavenger receptor class B member 1 are associated with insulin resistance with evidence of gene by sex interaction. J Clin Endocrinol Metab. 2009; 94: 1789-1796.
357. Simón I, Vendrell J, Gutiérrez C, et al. Pro12Ala substitution in the peroxisome proliferator-activated receptor-γ is associated with increased leptin levels in women with type-2 diabetes mellitus. Horm Res. 2002; 58: 143-149.
358. Zietz B, Barth N, Spiegel D, Schmitz G, Schölmerich J, Schäffler A. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-γ 2 (PPARγ 2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients. Exp Clin Endocrinol Diabetes. 2002; 110: 60-66.
359. Alkhalaf A, Landman GW, van Hateren KJ, et al. Sex specific association between carnosinase gene CNDP1 and cardiovascular mortality in patients with type 2 diabetes (ZODIAC-22). J Nephrol. 2015; 28: 201-207.
360. Lee EY, Lee YH, Kim SH, et al. Association between heme oxygenase-1 promoter polymorphisms and the development of albuminuria in type 2 diabetes: a case-control study. Medicine (Baltimore). 2015; 94: e1825.
361. Klimek P, Kautzky-Willer A, Chmiel A, Schiller-Frühwirth I, Thurner S. Quantification of diabetes comorbidity risks across life using nation-wide big claim data. PLoS Computer Biol. 2015; 11: e1004125.
362. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med. 2006; 23: 1165-1173.
363. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009; 26: 153-161.
364. Carpenter KM, Hasin DS, Allison DB, Faith MS. Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health. 2000; 90: 251-257.
365. Yang J, Cummings EA, O'connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol. 2006; 108: 644-650.
366. Kitahara CM, Flint AJ, Berrington de Gonzalez A, et al. Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. PLoS Med. 2014; 11: e1001673.
367. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. Amodelbased method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001; 24: 539-548.